# Aprea Therapeutics (APRE) — Earnings

APRE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/apre/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.53 |
| EPS estimate | −$0.71 |
| EPS surprise | +25.49% |
| Revenue surprise | +0.00% |
| Revenue | $118,111.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1781983/000155837025011152/apre-20250630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$0.71 | −$0.53 | 25.49% | — | $118,111.00 |
| Q1 2025 | May 14, 2025 | −$0.65 | −$0.66 | -0.87% | — | $162,463.00 |
| Q4 2024 | Mar 25, 2025 | −$0.66 | −$0.49 | 25.76% | $225,000.00 | $205,817.00 |
| Q3 2024 | Nov 7, 2024 | −$0.72 | −$0.64 | 10.66% | $225,000.00 | $354,621.00 |
| Q2 2024 | Aug 12, 2024 | −$0.62 | −$0.58 | 5.89% | $50,000.00 | $561,574.00 |
| Q1 2024 | May 14, 2024 | −$0.76 | −$0.67 | 11.84% | — | $380,569.00 |
| Q4 2023 | Mar 26, 2024 | −$0.77 | −$0.92 | -19.99% | $165,000.00 | $14,075.00 |
| Q3 2023 | Nov 9, 2023 | −$1.13 | −$0.86 | 23.67% | $125,000.00 | $319,468.00 |
| Q2 2023 | Aug 10, 2023 | −$1.43 | −$0.87 | 38.95% | — | $249,688.00 |
| Q1 2023 | May 15, 2023 | −$1.51 | −$1.34 | 10.96% | — | — |
| Q4 2022 | Mar 30, 2023 | −$2.60 | −$0.92 | 64.62% | — | — |
| Q3 2022 | Nov 9, 2022 | −$5.40 | −$2.40 | 55.56% | — | — |
| Q2 2022 | Aug 11, 2022 | −$6.20 | −$86.80 | -1300.00% | — | — |
| Q1 2022 | May 16, 2022 | −$7.60 | −$7.20 | 5.26% | — | — |
| Q4 2021 | Mar 15, 2022 | −$8.80 | −$7.20 | 18.18% | — | — |
| Q3 2021 | Nov 8, 2021 | −$9.05 | −$9.00 | 0.55% | — | — |
| Q2 2021 | Aug 12, 2021 | −$9.35 | −$9.60 | -2.67% | — | — |
| Q1 2021 | May 6, 2021 | −$9.85 | −$9.20 | 6.60% | — | — |
| Q4 2020 | Mar 16, 2021 | −$13.64 | −$14.60 | -7.04% | — | — |
| Q3 2020 | Nov 5, 2020 | −$15.20 | −$11.60 | 23.68% | — | — |

## Frequently Asked Questions

### When did Aprea Therapeutics (APRE) last report earnings?

Aprea Therapeutics last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did APRE beat earnings estimates?

Yes. Aprea Therapeutics reported EPS of −$0.53 for Q2 2025 against a −$0.71 estimate — a 25.49% beat.

### How much revenue did APRE report last quarter?

Aprea Therapeutics reported $118,111.00 in revenue for Q2 2025.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).